Neuropathic Gaucher disease

Wiener Medizinische Wochenschrift

Volumn 160, Issue 23-24, 2010, Pages 605-608

  Pastores, Gregory M ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow transplantation; Enzyme replacement therapy; Myoclonus; Neuropathic Gaucher disease

Indexed keywords

GLUCOSYLCERAMIDASE; SPHINGOLIPID ACTIVATOR PROTEIN;

ARTICLE; BONE MARROW TRANSPLANTATION; BRAIN ATROPHY; ENZYME REPLACEMENT; EVOKED AUDITORY RESPONSE; GAUCHER DISEASE; GENOTYPE PHENOTYPE CORRELATION; HEARING IMPAIRMENT; HOMOZYGOSITY; HUMAN; MYOCLONUS EPILEPSY; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; STRABISMUS; TONIC CLONIC SEIZURE;

BONE MARROW TRANSPLANTATION; ENZYME REPLACEMENT THERAPY; GAUCHER DISEASE; NEUROLOGIC EXAMINATION; PARKINSONIAN DISORDERS; PERIPHERAL NERVOUS SYSTEM DISEASES; PHENOTYPE; PROGNOSIS;

EID: 78751469450     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-010-0850-x     Document Type: Article

References (34)

1. RO Brady NW Barton GA Grabowski 1993 The role of neurogenetics in Gaucher disease Arch Neurol 50 11 1212 1224 1:STN:280:DyaK2c%2FivFKmsQ%3D%3D 8215980
2. RP Grewal SH Doppelt MA Thompson, et al. 1991 Neurologic complications of non-neuronopathic Gaucher's disease Arch Neurol 48 12 1271 1272 1:STN:280:DyaK3s3mtlygsw%3D%3D 1845033
3. P Giraldo JL Capablo P Alfonso, et al. 2008 Neurological manifestations in patients with Gaucher disease and in their relatives Med Clin (Barc) 131 5 175 179 10.1157/13124962 (Pubitemid 352018930)
4. J DePaolo O Goker-Alpan T Samaddar, et al. 2009 The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism Mov Disord 24 11 1571 1578 10.1002/mds.22538 19425057
5. O Goker-Alpan R Schiffmann ME LaMarca, et al. 2004 Parkinsonism among Gaucher disease carriers J Med Genet 41 12 937 940 1:STN:280: DC%2BD2cnhvVWhsA%3D%3D 10.1136/jmg.2004.024455 15591280 (Pubitemid 40007255)
6. DL Stone N Tayebi E Orvisky, et al. 2000 Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease Hum Mutat 15 2 181 188 1:CAS:528:DC%2BD3cXhsF2ksbo%3D 10.1002/(SICI)1098-1004(200002)15:2<181::AID- HUMU7>3.0.CO;2-S 10649495 (Pubitemid 30078409)
7. KS Hruska ME LaMarca CR Scott, et al. 2008 Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA) Hum Mutat 29 5 567 583 1:CAS:528:DC%2BD1cXmsVOgu74%3D 10.1002/humu.20676 18338393 (Pubitemid 351614580)
8. UH Schueler T Kolter CR Kaneski, et al. 2003 Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3 Neurobiol Dis 14 3 595 601 1:CAS:528:DC%2BD3sXpvVWktro%3D 10.1016/j.nbd.2003.08.016 14678774 (Pubitemid 37543536)
9. D Pelled S Trajkovic-Bodennec E Lloyd-Evans, et al. 2005 Enhanced calcium release in the acute neuronopathic form of Gaucher disease Neurobiol Dis 18 1 83 88 1:CAS:528:DC%2BD2MXkslOhug%3D%3D 10.1016/j.nbd.2004.09.004 15649698 (Pubitemid 40092898)
10. K Wong E Sidransky A Verma, et al. 2004 Neuropathology provides clues to the pathophysiology of Gaucher disease Mol Genet Metab 82 3 192 207 1:CAS:528:DC%2BD2cXlsVSgu74%3D 10.1016/j.ymgme.2004.04.011 15234332 (Pubitemid 38952652)
11. IB Enquist C Lo Bianco A Ooka, et al. 2007 Murine models of acute neuronopathic Gaucher disease Proc Natl Acad Sci USA 104 44 17483 17488 1:CAS:528:DC%2BD2sXht1ymtrfN 10.1073/pnas.0708086104 17954912 (Pubitemid 350219864)
12. Y Sun B Liou H Ran, et al. 2010 Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits Hum Mol Genet 19 6 1088 1097 1:CAS:528:DC%2BC3cXivV2jtL0%3D 10.1093/hmg/ddp580 20047948
13. AM Vaccaro M Motta M Tatti, et al. 2010 Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting Hum Mol Genet 19 15 2987 2997 1:CAS:528:DC%2BC3cXhtVahsLnE 10.1093/hmg/ddq204 20484222
14. J Blanz J Groth C Zachos, et al. 2010 Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase Hum Mol Genet 19 4 563 572 1:CAS:528:DC%2BC3cXmsl2qtA%3D%3D 10.1093/hmg/ddp523 19933215
15. A Tylki-Szymańska A Vellodi A El-Beshlawy, et al. 2010 Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry J Inherit Metab Dis 33 4 339 346 10.1007/s10545-009-9009-6 20084461
16. DL Stone WF Carey J Christodoulou, et al. 2000 Type 2 Gaucher disease: the collodion baby phenotype revisited Arch Dis Child Fetal Neonatal Ed 82 2 F163 F166 1:STN:280:DC%2BD3c7ltVentQ%3D%3D 10.1136/fn.82.2.F163 10685993
17. Kraoua I, Sedel F, Caillaud C, et al. A French experience of type 3 Gaucher disease: Phenotypic diversity and neurological outcome of 10 patients. Brain Dev, 2010 Mar. 20. [Epub ahead of print]
18. DE Bamiou P Campbell A Liasis, et al. 2001 Audiometric abnormalities in children with Gaucher disease type 3 Neuropediatrics 32 3 136 141 1:STN:280:DC%2BD3MvnslGntA%3D%3D 10.1055/s-2001-16611 11521209 (Pubitemid 32747625)
19. EH Davies R Surtees C DeVile, et al. 2007 A severity scoring tool to assess the neurological features of neuronopathic Gaucher disease J Inherit Metab Dis 30 5 768 782 1:STN:280:DC%2BD2sngt1SisA%3D%3D 10.1007/s10545-007-0595- x 17876722 (Pubitemid 47559890)
20. M Biegstraaten IN van Schaik JM Aerts, et al. 2008 'Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature J Inherit Metab Dis 31 3 337 349 1:STN:280:DC%2BD1czovFegsg%3D%3D 10.1007/s10545-008-0832-y 18404411
21. J Mitsui I Mizuta A Toyoda, et al. 2009 Mutations for Gaucher disease confer high susceptibility to Parkinson disease Arch Neurol 66 5 571 576 10.1001/archneurol.2009.72 19433656
22. K Kalinderi S Bostantjopoulou C Paisan-Ruiz, et al. 2009 Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece Neurosci Lett 452 2 87 89 1:CAS:528:DC%2BD1MXit1OjtrY%3D 10.1016/j.neulet.2009.01.029 19383421
23. E Sidransky MA Nalls JO Aasly, et al. 2009 Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease N Engl J Med 361 17 1651 1661 1:CAS:528:DC%2BD1MXhtlWgs77P 10.1056/NEJMoa0901281 19846850
24. E Beutler L Beutler C West 2004 Mutations in the gene encoding cytosolic beta-glucosidase in Gaucher disease J Lab Clin Med 144 2 65 68 1:CAS:528:DC%2BD2cXmvFWls7s%3D 10.1016/j.lab.2004.03.013 15322500 (Pubitemid 39119804)
25. G Bultron K Kacena D Pearson, et al. 2010 The risk of Parkinson's disease in type 1 Gaucher disease J Inherit Metab Dis 33 2 167 173 10.1007/s10545-010- 9055-0 20177787
26. V Koprivica DL Stone JK Park, et al. 2000 Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease Am J Hum Genet 66 6 1777 1786 1:CAS:528:DC%2BD3cXntV2jtbo%3D 10.1086/302925 10796875 (Pubitemid 30480085)
27. JK Park E Orvisky N Tayebi, et al. 2003 Myoclonic epilepsy in Gaucher disease: genotype-phenotype insights from a rare patient subgroup Pediatr Res 53 3 387 395 10.1203/01.PDR.0000049515.79882.94 12595585 (Pubitemid 36237392)
28. R George J McMahon B Lytle B Clark A Lichtin 2001 Severe valvular and aortic arch calcification in a patient with Gaucher's disease homozygous for the D409H mutation Clin Genet 59 5 360 363 1:STN:280:DC%2BD3M3ns1Sgug%3D%3D 10.1034/j.1399-0004.2001.590511.x 11359469 (Pubitemid 32451976)
29. H Michelakakis M Moraitou E Dimitriou, et al. 2006 Homozygosity for the double D409H+H255Q allele in type II Gaucher disease J Inherit Metab Dis 29 4 591 1:CAS:528:DC%2BD28Xnsl2ju7s%3D 10.1007/s10545-006-0316-x 16830265
30. Somaraju UR, Tadepalli K. Hematopoietic stem cell transplantation for Gaucher disease. Cochrane Database Syst Rev, (4): CD006974, 2008
31. A Vellodi A Tylki-Szymanska EH Davies, et al. 2009 Management of neuronopathic Gaucher disease: revised recommendations J Inherit Metab Dis 32 5 660 664 1:STN:280:DC%2BD1MjgtVGhug%3D%3D 10.1007/s10545-009-1164-2 19655269
32. PE Campbell CM Harris A Vellodi 2004 Deterioration of the auditory brainstem response in children with type 3 Gaucher disease Neurology 63 2 385 387 15277647
33. O Goker-Alpan EA Wiggs MJ Eblan, et al. 2008 Cognitive outcome in treated patients with chronic neuronopathic Gaucher disease J Pediatr 153 1 89 94 10.1016/j.jpeds.2007.12.023 18571543
34. R Schiffmann EJ Fitzgibbon C Harris, et al. 2008 Randomized, controlled trial of miglustat in Gaucher's disease type 3 Ann Neurol 64 5 514 522 10.1002/ana.21491 19067373